Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
IMIDACLOPRID, PERMETHRIN
Krka, d.d., Novo mesto
QP53AC54
IMIDACLOPRID, PERMETHRIN
100+500
Spot On Solution
POM
Canine
Permethrin, combinations
Ectoparasiticide
Authorised
2015-10-30
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1.0 ml pipette contains: ACTIVE SUBSTANCES: Permethrin 500.0 mg Imidacloprid 100.0 mg EXCIPIENTS: Butylhydroxytoluene (E321) 1 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Spot-on solution. Clear yellowish to brownish solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment and prevention of flea (_Ctenocephalides felis_) infestation. Fleas on dogs are killed within one day following treatment. One treatment prevents further flea infestation for four weeks. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). The product has persistent acaricidal efficacy against tick infestations (_Rhipicephalus sanguineus _and _Ixodes ricinus_ for four weeks, and _Dermacentor reticulatus _for three weeks). Ticks already on the dog may not be killed within two days after treatment and may remain attached and visible. Therefore the removal of ticks already on the dog at the time of treatment is recommended, in order to prevent them from attaching and having a blood meal. 4.3 CONTRAINDICATIONS In the absence of available data do not use the product on puppies of less than 7 weeks of age, or 4 kg of weight. Do not use in case of hypersensitivity to the active substances or to any of the excipients. Do not use on cats. (Refer to section 4.5 – Special precautions for use). HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 30/10/2015_ _CRN 7018455_ _page number: 1 Citiți documentul complet